Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2013 1
2014 3
2015 1
2016 4
2017 4
2018 4
2019 3
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Targeting renal fibrosis: Mechanisms and drug delivery systems.
Nastase MV, Zeng-Brouwers J, Wygrecka M, Schaefer L. Nastase MV, et al. Among authors: zeng brouwers j. Adv Drug Deliv Rev. 2018 Apr;129:295-307. doi: 10.1016/j.addr.2017.12.019. Epub 2017 Dec 27. Adv Drug Deliv Rev. 2018. PMID: 29288033 Review.
Podocyte Integrin-β 3 and Activated Protein C Coordinately Restrict RhoA Signaling and Ameliorate Diabetic Nephropathy.
Madhusudhan T, Ghosh S, Wang H, Dong W, Gupta D, Elwakiel A, Stoyanov S, Al-Dabet MM, Krishnan S, Biemann R, Nazir S, Zimmermann S, Mathew A, Gadi I, Rana R, Zeng-Brouwers J, Moeller MJ, Schaefer L, Esmon CT, Kohli S, Reiser J, Rezaie AR, Ruf W, Isermann B. Madhusudhan T, et al. Among authors: zeng brouwers j. J Am Soc Nephrol. 2020 Aug;31(8):1762-1780. doi: 10.1681/ASN.2019111163. Epub 2020 Jul 24. J Am Soc Nephrol. 2020. PMID: 32709711 Free PMC article.
Soluble biglycan as a biomarker of inflammatory renal diseases.
Hsieh LT, Nastase MV, Zeng-Brouwers J, Iozzo RV, Schaefer L. Hsieh LT, et al. Among authors: zeng brouwers j. Int J Biochem Cell Biol. 2014 Sep;54:223-35. doi: 10.1016/j.biocel.2014.07.020. Epub 2014 Aug 1. Int J Biochem Cell Biol. 2014. PMID: 25091702 Free PMC article. Review.
Progranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus.
Hardt S, Valek L, Zeng-Brouwers J, Wilken-Schmitz A, Schaefer L, Tegeder I. Hardt S, et al. Among authors: zeng brouwers j. Aging Dis. 2018 Oct 1;9(5):817-830. doi: 10.14336/AD.2017.1127. eCollection 2018 Oct. Aging Dis. 2018. PMID: 30271659 Free PMC article.
Biglycan is a new high-affinity ligand for CD14 in macrophages.
Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C, Hsieh LT, Brandts C, Fulda S, Wygrecka M, Schaefer L. Roedig H, et al. Among authors: zeng brouwers j. Matrix Biol. 2019 Apr;77:4-22. doi: 10.1016/j.matbio.2018.05.006. Epub 2018 May 17. Matrix Biol. 2019. PMID: 29777767
Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis in ischemia/reperfusion injury.
Poluzzi C, Nastase MV, Zeng-Brouwers J, Roedig H, Hsieh LT, Michaelis JB, Buhl EM, Rezende F, Manavski Y, Bleich A, Boor P, Brandes RP, Pfeilschifter J, Stelzer EHK, Münch C, Dikic I, Brandts C, Iozzo RV, Wygrecka M, Schaefer L. Poluzzi C, et al. Among authors: zeng brouwers j. Kidney Int. 2019 Mar;95(3):540-562. doi: 10.1016/j.kint.2018.10.037. Epub 2019 Jan 31. Kidney Int. 2019. PMID: 30712922
Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney.
Nastase MV, Zeng-Brouwers J, Beckmann J, Tredup C, Christen U, Radeke HH, Wygrecka M, Schaefer L. Nastase MV, et al. Among authors: zeng brouwers j. Matrix Biol. 2018 Aug;68-69:293-317. doi: 10.1016/j.matbio.2017.12.002. Epub 2017 Dec 15. Matrix Biol. 2018. PMID: 29253517
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page